John Robert Vane
Impact in
- Biochemistry top 0.01%
- Eicosanoids and Hypertension Pharmacology
- Pharmacology top 0.01%
- Inflammatory mediators and NSAID effects
Papers in
- Biochemistry 150
- Eicosanoids and Hypertension Pharmacology 146
- Pharmacology 194
- Inflammatory mediators and NSAID effects 173
- Co-authors
- Salvador Moncada (103 shared papers)Renia M. Botting (22 shared papers)Christoph Thiemermann (56 shared papers)Ryszard Jerzy Gryglewski (10 shared papers)Sergio H. Ferreira (19 shared papers)Jane A. Mitchell (24 shared papers)S Bunting (14 shared papers)Regina M. Botting (12 shared papers)
- Journals
- British Journal of Pharmacology (84 papers)Nature (41 papers)Proceedings of the National Academy of Sciences (28 papers)Journal of Cardiovascular Pharmacology (26 papers)Prostaglandins (26 papers)
- Partner nations
- United KingdomUnited StatesPoland
In The Last Decade
John Robert Vane
493 papers receiving 61.7k citations
John Robert Vane's Hit Papers
Peers
Comparison fields: 5 of 177
- Biochemistry 13.0k
- Pharmacology 26.8k
- Physiology 18.7k
- Cardiology and Cardiovascular Medicine 12.7k
- Pharmacology 5.0k
Countries citing papers authored by John Robert Vane
This map shows the geographic impact of John Robert Vane's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Robert Vane with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Robert Vane more than expected).
Fields of papers citing papers by John Robert Vane
This network shows the impact of papers produced by John Robert Vane. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Robert Vane. The network helps show where John Robert Vane may publish in the future.
Co-authors
The 25 scholars most cited alongside John Robert Vane, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 506 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Inhibition of Prostaglandin Synthesis as a Mechanism of Action for Aspirin-like Drugs Hit paper breakdown → | 1971 | 7461 |
| 2 | An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation Hit paper breakdown → | 1976 | 3123 |
| 3 | CYCLOOXYGENASES 1 AND 2 Hit paper breakdown → | 1998 | 2425 |
| 4 | Regulatory Functions of the Vascular Endothelium Hit paper breakdown → | 1990 | 1636 |
| 5 | Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase. Hit paper breakdown → | 1993 | 1461 |
| 6 | Pharmacology and endogenous roles of prostaglandin endoperoxides, thromboxane A2, and prostacyclin. Hit paper breakdown → | 1978 | 1419 |
| 7 | Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: A full in vitro analysis Hit paper breakdown → | 1999 | 1337 |
| 8 | Pressor effects of circulating endothelin are limited by its removal in the pulmonary circulation and by the release of prostacyclin and endothelium-derived relaxing factor. Hit paper breakdown → | 1988 | 1246 |
| 9 | Arachidonic Acid Metabolites and the Interactions between Platelets and Blood-Vessel Walls Hit paper breakdown → | 1979 | 1005 |
| 10 | The mechanism of action of aspirin Hit paper breakdown → | 2003 | 967 |
| 11 | Inducible isoforms of cyclooxygenase and nitric-oxide synthase in inflammation. Hit paper breakdown → | 1994 | 957 |
| 12 | Arterial walls are protected against deposition of platelet thrombi by a substance (prostaglandin X) which they make from prostaglandin endoperoxides Hit paper breakdown → | 1976 | 910 |
| 13 | Arterial walls generate from prostaglandin endoperoxides a substance (prostaglandin X) which relaxes strips of mesenteric and coeliac arteries and inhibits platelet aggregation Hit paper breakdown → | 1976 | 868 |
| 14 | Indomethacin and Aspirin abolish Prostaglandin Release from the Spleen Hit paper breakdown → | 1971 | 848 |
| 15 | Prostaglandins: Their Disappearance from and Release into the Circulation Hit paper breakdown → | 1967 | 818 |
| 16 | Release of Additional Factors in Anaphylaxis and its Antagonism by Anti-inflammatory Drugs Hit paper breakdown → | 1969 | 801 |
| 17 | HUMAN ARTERIAL AND VENOUS TISSUES GENERATE PROSTACYCLIN (PROSTAGLANDIN X), A POTENT INHIBITOR OF PLATELET AGGREGATION Hit paper breakdown → | 1977 | 763 |
| 18 | New insights into the mode of action of anti-inflammatory drugs Hit paper breakdown → | 1995 | 725 |
| 19 | A SENSITIVE METHOD FOR THE ASSAY OF 5‐HYDROXYTRYPTAMINE Hit paper breakdown → | 1957 | 719 |
| 20 | Inhibition of Prostaglandin Synthetase in Brain explains the Anti-pyretic Activity of Paracetamol (4-Acetamidophenol) Hit paper breakdown → | 1972 | 677 |
About John Robert Vane
John Robert Vane is a scholar working on Biochemistry, Pharmacology, Physiology, Cardiology and Cardiovascular Medicine and Pharmacology, having authored 506 papers that have together received 70.4k indexed citations. Recurring topics across this work include Nitric Oxide and Endothelin Effects (179 papers), Inflammatory mediators and NSAID effects (173 papers), Eicosanoids and Hypertension Pharmacology (146 papers), Antiplatelet Therapy and Cardiovascular Diseases (49 papers), Renin-Angiotensin System Studies (48 papers), Receptor Mechanisms and Signaling (41 papers), Neuropeptides and Animal Physiology (37 papers) and Cardiac Ischemia and Reperfusion (33 papers). The work is most often cited by research in Biochemistry (13.0k citations), Pharmacology (26.8k citations), Physiology (18.7k citations), Cardiology and Cardiovascular Medicine (12.7k citations) and Pharmacology (5.0k citations). John Robert Vane has collaborated with scholars based in United Kingdom, United States and Poland. Frequent co-authors include Salvador Moncada, Renia M. Botting, Christoph Thiemermann, Ryszard Jerzy Gryglewski, Sergio H. Ferreira, Jane A. Mitchell, S Bunting, Regina M. Botting, Timothy David Warner and Y.S. Bakhle. Their work appears in journals such as British Journal of Pharmacology, Nature, Proceedings of the National Academy of Sciences, Journal of Cardiovascular Pharmacology and Prostaglandins.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.